A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma

NCT06343935 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Indolent B-cell Lymphoma

Interventions

DRUG: Linperlisib

Sponsor

Shanghai YingLi Pharmaceutical Co. Ltd.